BSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹51.44
- Market cap
- ₹70.58 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 14.4×Sector 34.8×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 23.1% YoY
Eiko Lifesciences Ltd reported revenue from operations of ₹17.7 Cr (+51.3% YoY) and net profit of ₹1.6 Cr (+23.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +23.1% YoY
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Eiko Lifesciences Convertible Warrants
Eiko Lifesciences allotted 1,50,000 equity shares upon conversion of warrants, receiving a balance payment of Rs. 0.62 Crore from promoter Lenus Finvest Private Limited.
- Value
- ₹0.62 Cr
- From
- Lenus Finvest Private Limited
Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
Other merger & restructuring announcements
All →SecMark Consultancy Merger & Restructuring Worth ₹0.01 Cr
SecMark Consultancy's board approved incorporating wholly owned subsidiary SecMark Mineral Exchange Private Limited. The company will subscribe Rs 1 lakh for its initial share capital.
- Value
- ₹0.01 Cr
Powerica Merger & Restructuring Worth ₹2.12 Cr
Powerica plans to sell a 49% stake in Windstride Power to GE Renewable for ₹2.12 Crore cash. Completion is expected within six months, by May 2027.
- Value
- ₹2.12 Cr
Welspun Enterprises Merger & Restructuring Worth ₹339.4 Cr
Welspun Enterprises completed the final tranche sale of its 51% stake in associate NXT Infra MCP to NXT-Infra Trust for about ₹339.38 Crore. NXT Infra MCP ceases to be an associate of the company.
- Value
- ₹339.4 Cr
Rashi Peripherals Merger & Restructuring
Rashi Peripherals' board approved a share purchase and shareholders' agreement to sell 26% of subsidiary Rashi Semiconductor Solutions to Restar Corporation, Japan. Execution remains subject to approvals.
Span Divergent Merger & Restructuring Worth ₹5 Cr
Span Divergent's board approved selling its Mumbai immovable property to Glorious Sales LLP, an unrelated buyer, for up to Rs.5 Crore. Completion is expected by March 31, 2027.
- Value
- ₹5.00 Cr
- Execution
- Agreement to be executed on or before March 31, 2027; sale expected to complete on or before March 31, 2027
Sunteck Realty Merger & Restructuring Worth ₹0.01 Cr
Sunteck Realty incorporated a wholly owned subsidiary, Eminara Real Estates Private Limited. The Rs 1 lakh subscription is a small real estate expansion step.
- Value
- ₹0.01 Cr